You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?
Embla Medical – A look back at 2024 with CEO
With a share price return of +30%, Embla Medical has outperformed both the Danish stock market and the European Medtech sector. Together with Embla Medical’s CEO Sveinn Solvason, we looked back at the main achievements in 2024 and the key drivers behind the results.
In the interview, you can hear more about the main headlines for Embla Medical, how 2024 has positioned the company to deliver on the 2027 strategy, and lastly which milestones investors should look out for in 2025.
Disclaimer: HC Andersen Capital receives payment from Embla Medical for a Corporate Visibility/Digital IR subscription agreement. /Michael Friis, 09:26, 06-12-2024.